Am J Transplant, Volume 5, Suppl 3 Archives - Page 48 of 170 - ATC Abstracts

2015 American Transplant Congress
Single Center Experience With the Use of an Abbreviated Anti-Thymocyte Globulin and Basiliximab Combination Protocol in Renal Transplantation
V. Whittaker,¹ D. Halleran,¹ S. Narsipar,¹ J. Melancon.²
¹Surgery, State University New York Upstate Medical University, Syracuse, NY; ²Surgery, George Washington University, Washington, DC.
Purpose: To report one year outcomes from single center experience with a novel induction regimen using anti-thymocyte globulin ( ATG)(rabbit)rATG (3 mg/kg) in divided doses…
2015 American Transplant Congress
Largest Single Center Experience of Pre-Transplant Outcomes After Bariatric Surgery in Ethnic Minorities With Chronic Kidney Disease
I. Thomas,² J. Gaynor,¹ T. Joseph,¹ N. De La Cruz,¹ D. Roth,² A. Mattiazzi,² W. Kupin,² L. Chen,¹ G. Burke,¹ M. Goldstein,¹ G. Ciancio,¹ G. Guerra.²
¹Surgery, University of Miami/Jackson Memorial Hospital, Miami, FL; ²Medicine, University of Miami/Jackson Memorial Hospital Miami Transplant Institute, Miami, FL, United Kingdom.
Background:Ethnic minorities have disproportionately lower renal transplant rates. The increased prevalence of obesity seen in ethnic minorities further places them at a disadvantage due to…
2015 American Transplant Congress
Sofosbuvir-Based Therapy for Hepatitis C Recurrence Post Liver Transplantation
A. Ajlan,¹ A. Aljedai,¹ H. Elsiesy,² D. Alkortas,¹ R. Alarieh,² F. Aba Alkhail.²
¹Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; ²Liver And Small Bowel Trans and Hep/Pancreatic Surgey -Organ Transplant Centre (OTC), King Faisal Specialist Hospital and Research Centre, Riaydh, Saudi Arabia.
Introduction:Sofosbuvir is approved to treat HCV infection in all genotypes with sustained virological response 12 weeks after completion of therapy (SVR12)rates of up to 100%.…
2015 American Transplant Congress
Safety and Efficacy of Early Everolimus in De Novo Orthotopic Liver Transplantation
M. Gastaca,¹ I. Bilbao,² M. Jimenez,³ J. Bustamente,¹ C. Dopazo,² R. Gonzalez,³ R. Charco,² J. Santoyo,⁴ J. Ortiz de Urbina.¹
¹Liver Transplantation Unit, Cruces University Hospital. University of the Basque Country, Bilbao, Vizcaya, Spain; ²Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitario Vall d´Hebron, Barcelona, Spain; ³Unidad de Hepatología-Trasplante Hepático, Hospital Regional Universitario de Malaga, Malaga, Spain; ⁴Unidad de Cirugía Hepatobiliar-Trasplante Hepático, Hospital Regional Universitario de Malaga, Malaga, Spain.
Purpose: To study the safety and efficacy of immunosuppression with Everolimus (EVL) within the first month after orthotopic liver transplantation.Patients and methods: Recipients who had…
2015 American Transplant Congress
Day of Week Influences Kidney Utilization
K. Foley, M. Chiles, S. Mohan.
Department of Medicine, Columbia University Medical Center, New York, NY.
Background: From 2000 to 2013, 17% of all kidneys procured for transplantation from deceased organ donors in the United States were discarded. The high rate…
2015 American Transplant Congress
Emerging Application of Active Immune Targeted Delivery in Transplantation
M. Uehara,¹ A. Jamil,¹ M. McGrath,¹ Z. Solhjou,¹ N. Banouni,¹ S. Tullius,² C. Jianjun,³ R. Abdi.¹
¹Renal Division, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical Shcool, Boston, MA; ²Division of Transplant Surgery, Brigham and Women's Hospital, Boston, MA; ³Materials Science and Engineering, University of Illinois at Urbana-Champaign, Champaingn, IL.
Targeted nanodelivery has created enormous excitement as a transformative approach to deliver therapeutics to tissues of interest. In recent years, we have made significant progress…
2015 American Transplant Congress
IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections Through Induction of IL-13 Production by CD4⁺ T Cells
H. Cho,^1,2 J. Lee,^2,3 V. Tran,⁴ H. Kim,^2,4 J. Kim,^2,4 B. Kwon.^2,4
¹Surgery, Ulsan University Hospital, Ulsan, Korea; ²Biomedical Research Center, Ulsan University Hospital, Ulsan, Korea; ³Internal Medicine, Ulsan University Hospital, Ulsan, Korea; ⁴School of Biological Sciences, University of Ulsan, Ulsan, Korea.
Susceptibility to systemic Candida albicans infection is determined not only by immune resistance but also by the ability to control Candida-induced immunopathologies. We previously showed…
2015 American Transplant Congress
Allograft Enterectomy as a Life-Saving Procedure and Salvage for Retransplantation
S. Nagai, R. Mangus, B. Ekser, C. Kubal, J. Fridell, A. Tector.
Transplant Surgery, Indiana University School of Medicine, Indianapolis, IN.
Background: Allgraftectomy after solid organ transplantation is usually performed as a palliative therapy. After isolated intestinal transplantation (IIT), allograft enterectomy is sometimes necessary as a…
2015 American Transplant Congress
DSA Monitoring in Kidney Transplant Recipients
F. Pean,¹ M. Cooper,¹ J. Verbesey,¹ A. Gilbert,¹ B. Javaid,¹ R. Mohammed,¹ O. Timofeeva,² J. Moore,¹ K. Cruz,¹ R. Ghasemian,¹ T. Fishbein,¹ M. Grafals.¹
¹Medstar Georgetown Transplant Institute, Georgetown University, Washington, DC; ²Clinical Laboratory and Histocompatibility, Georgetown University, Washington, DC.
Introduction: The development of DSA monitoring is a new technique to detect antibodies in kidney transplant recipients. Data has shown that development of DSA post…
2015 American Transplant Congress
Increased Length of Stay After Heart Transplant: What Are the Risk Factors?
A. Velleca, M. Kittleson, N. Perry, J. Patel, F. Liou, S. Siddiqui, J. Rush, D. Ramzy, L. Czer, D. Chang, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: Initial hospital length of stay following heart transplant is variable. The longer the hospital stay, the increased cost related to the surgery. This will…